Comment from Critical Path Institute

Summary: The Critical Path Institute, a nonprofit organization focused on medical product development, submitted comments to improve the utility and clarity of the draft guidance on AI in regulatory decision-making. They recommend specific technical additions, such as clarifying the application to generative AI, providing guidance on handling missing data, and establishing standardized documentation templates to align industry expectations.